Population-specific frequencies for LRRK2 susceptibility variants in the genetic epidemiology of Parkinson's disease (GEO-PD) consortium

Movement Disorders

Volumn 28, Issue 12, 2013, Pages 1740-1744

  Heckman, Michael G ^a   Soto Ortolaza, Alexandra I ^b   Aasly, Jan O ^c   Abahuni, Nadine ^d   Annesi, Grazia ^e   Bacon, Justin A ^b   Bardien, Soraya ^f   Bozi, Maria ^g   Brice, Alexis ^h,i,j,k   Brighina, Laura ^l   Carr, Jonathan ^f   Chartier Harlin, Marie Christine ^i,m   Dardiotis, Efthimios ^n,o   Dickson, Dennis W ^b   Diehl, Nancy N ^a   Elbaz, Alexis ^i,p   Ferrarese, Carlo ^l   Fiske, Brian ^q   Gibson, J Mark ^r   Gibson, Rachel ^s   Hadjigeorgiou, Georgios M ^n,o   Hattori, Nobutaka ^t   Ioannidis, John P A ^u,v   Boczarska Jedynak, Magdalena ^w   Jasinska Myga, Barbara ^w   Jeon, Beom S ^x   Kim, Yun Joong ^y   Klein, Christine ^z   Kruger, Rejko ^aa   Kyratzi, Elli ^ab   Lesage, Suzanne ^h,i,j   Lin, Chin Hsien ^ac   Lynch, Timothy ^ad   Maraganore, Demetrius M ^ae   Mellick, George D ^af   Mutez, Eugénie ^i,m,ag   Nilsson, Christer ^ah   Opala, Grzegorz ^w   Park, Sung Sup ^x   Petrucci, Simona ^ai   Puschmann, Andreas ^ah,aj   Quattrone, Aldo ^ak   Sharma, Manu ^aa   Silburn, Peter A ^al   Sohn, Young Ho ^am   Stefanis, Leonidas ^ab   Tadic, Vera ^z   Theuns, Jessie ^an,ao   Tomiyama, Hiroyuki ^t   Uitti, Ryan J ^a   Valente, Enza Maria ^ai   Van Broeckhoven, Christine ^an,ao   Van De Loo, Simone ^d   Vassilatis, Demetrios K ^ab   Vilariño Güell, Carles ^ap   White, Linda R ^c   Wirdefeldt, Karin ^aq   Wszolek, Zbigniew K ^a   Wu, Ruey Meei ^ac   Hentati, Faycal ^ar   Farrer, Matthew J ^ap   Ross, Owen A ^b   more..

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^d GOETHE UNIVERSITY   (Germany)

^e INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

^f STELLENBOSCH UNIVERSITY   (South Africa)

^g General Hospital of Syros   (Greece)

^h SORBONNE UNIVERSITÉ   (France)

ⁱ INSERM   (France)

^j CNRS   (France)

^k ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^l SAN GERARDO HOSPITAL   (Italy)

^m UNIV LILLE   (France)

ⁿ UNIVERSITY OF THESSALY   (Greece)

^o INSTITUTE OF HUMAN PERFORMANCE AND REHABILITATION   (Greece)

^p CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^q THE MICHAEL J FOX FOUNDATION FOR PARKINSON'S RESEARCH   (United States)

^r ROYAL VICTORIA HOSPITAL   (United Kingdom)

^s GLAXOSMITHKLINE   (United Kingdom)

^t JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^u UNIVERSITY OF IOANNINA   (Greece)

^v STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^w MEDICAL UNIVERSITY OF SILESIA   (Poland)

^x Seoul National University Hospital   (South Korea)

^y Hallym University   (South Korea)

^z UNIVERSITY OF LÜBECK   (Germany)

^aa UNIVERSITY OF TÜBINGEN   (Germany)

^ab BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^ac NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^ad UNIVERSITY COLLEGE DUBLIN   (Ireland)

^ae NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^af GRIFFITH UNIVERSITY   (Australia)

^ag LILLE UNIVERSITY HOSPITAL   (France)

^ah LUND UNIVERSITY   (Sweden)

^ai CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^aj LUND UNIVERSITY HOSPITAL   (Sweden)

^ak UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^al UNIVERSITY OF QUEENSLAND   (Australia)

^am Yonsei University College of Medicine   (South Korea)

^an DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^ao UNIVERSITY OF ANTWERP   (Belgium)

^ap UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^aq KAROLINSKA INSTITUTE   (Sweden)

^ar Institut National de Neurologie Tunisia   (Tunisia)

more..

Author keywords

Association study; Genetics; LRRK2; Parkinson's disease

Indexed keywords

LEUCINE RICH REPEAT KINASE 2;

ALLELE; ALZHEIMER DISEASE; ARTICLE; DISEASE PREDISPOSITION; DYSKINESIA; GENE FREQUENCY; GENETIC EPIDEMIOLOGY; GENETIC RISK; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; IMPULSE CONTROL DISORDER; PARKINSON DISEASE; PRIORITY JOURNAL; RISK FACTOR;

ASSOCIATION STUDY; GENETICS; LRRK2; PARKINSON'S DISEASE;

GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; GENOTYPE; HAPLOTYPES; HUMANS; MOLECULAR EPIDEMIOLOGY; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES;

EID: 84886446293     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25600     Document Type: Article

References (15)

1. Elbaz A, Ross OA, Ioannidis JP, et al. Independent and joint effects of the MAPT and SNCA genes in Parkinson disease. Ann Neurol 2011;69:778-792.
2. Lill CM, Roehr JT, McQueen MB, et al. Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: the PDGene database [serial online]. PLoS Genet 2012;8:e1002548.
3. Sundal C, Fujioka S, Uitti RJ, Wszolek ZK. Autosomal dominant Parkinson's disease. Parkinsonism Relat Disord 2012;18(suppl 1):S7-S10.
4. Ross OA, Soto-Ortolaza AI, Heckman MG, et al. Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study. Lancet Neurol 2011;10:898-908.
5. Tan EK, Peng R, Teo YY, et al. Multiple LRRK2 variants modulate risk of Parkinson disease: a Chinese multicenter study. Hum Mutat 2010;31:561-568.
6. Nalls MA, Plagnol V, Hernandez DG, et al. Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet 2011;377:641-649.
7. Satake W, Nakabayashi Y, Mizuta I, et al. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat Genet 2009;41:1303-1307.
8. Bateman RJ, Xiong C, Benzinger TL, et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med 2012;367:795-804.
9. Hinkle KM, Yue M, Behrouz B, et al. LRRK2 knockout mice have an intact dopaminergic system but display alterations in exploratory and motor co-ordination behaviors [serial online]. Mol Neurodegener 2012;7:25.
10. Tong Y, Yamaguchi H, Giaime E, et al. Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of alpha-synuclein, and apoptotic cell death in aged mice. Proc Natl Acad Sci U S A 2010;107:9879-9884.
11. Maraganore DM, de Andrade M, Elbaz A, et al. Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. JAMA 2006;296:661-670.
12. Singleton AB, Farrer M, Johnson J, et al. alpha-Synuclein locus triplication causes Parkinson's disease [serial online]. Science 2003;302:841.
13. Ross OA, Braithwaite AT, Skipper LM, et al. Genomic investigation of alpha-synuclein multiplication and parkinsonism. Ann Neurol 2008;63:743-750.
14. Vilarino-Guell C, Wider C, Ross OA, et al. VPS35 mutations in Parkinson disease. Am J Hum Genet 2011;89:162-167.
15. Zimprich A, Benet-Pages A, Struhal W, et al. A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. Am J Hum Genet 2011;89:168-175.